全球多模態成像市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

多模態成像市場預計將從 2025 年的 52.2 億美元成長到 2034 年的 83.8 億美元，2026 年至 2034 年的複合年成長率為 5.41%。

由於對綜合診斷解決方案的需求不斷成長，全球多模態成像市場正經歷穩定成長。多模態影像結合了多種影像技術，例如PET/CT和MRI/CT，以提供詳細的解剖和功能資訊。慢性疾病的日益普遍推動了其在腫瘤學和神經病學領域的應用。

關鍵成長要素包括成像技術的進步及其與人工智慧分析工具的融合。醫療服務提供者正在投資混合成像系統以提高診斷準確性。醫療基礎設施的擴建和醫學影像研究的進步進一步推動了市場成長。此外，人們對疾病早期檢測的日益重視也增強了市場需求。

展望未來，提升影像解析度和工作流程效率的技術創新可望推動市場發展。新興市場對診斷設施的升級改造將創造新的成長機會。各公司正致力於研發緊湊、經濟高效的混合系統。隨著精準診斷技術的進步，全球多模態影像市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球多模態影像市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 試劑
• 軟體

第5章 全球多模態影像市場：依技術分類

• 市場分析、洞察與預測
• PET/CT系統
• SPECT/CT系統
• PET/MR系統
• 光學相干斷層掃描/眼底成像系統
• 其他多模態成像系統

第6章 全球多模態影像市場：依應用分類

• 市場分析、洞察與預測
• 腫瘤學
• 眼科
• 心臟病學
• 神經科學
• 其他用途

第7章 全球多模態影像市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診斷影像中心
• 其他

第8章 全球多模態影像市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • GE Healthcare
  • Siemens Healthcare GmbH
  • Toshiba Medical Systems Corporation
  • Hitachi Medical Systems
  • Samsung Medison Co.Ltd
  • Koninklijke Philips NV
  • Shimadzu Corporation
  • Carestream Health
  • Fujifilm Holdings
  • Esaote

The Multimodal Imaging Market size is expected to reach USD 8.38 Billion in 2034 from USD 5.22 Billion (2025) growing at a CAGR of 5.41% during 2026-2034.

The Global Multimodal Imaging Market is witnessing steady growth due to increasing demand for comprehensive diagnostic solutions. Multimodal imaging combines different imaging techniques such as PET/CT and MRI/CT to provide detailed anatomical and functional information. Rising prevalence of chronic diseases is driving adoption in oncology and neurology.

Key growth drivers include advancements in imaging technologies and integration with AI-based analysis tools. Healthcare providers are investing in hybrid imaging systems to improve diagnostic accuracy. Expanding healthcare infrastructure and growing research in medical imaging are further supporting market expansion. Additionally, increasing focus on early disease detection is strengthening demand.

Looking ahead, the market is expected to benefit from technological innovations enhancing image resolution and workflow efficiency. Emerging markets upgrading diagnostic facilities will create new growth opportunities. Companies are focusing on compact and cost-effective hybrid systems. As precision diagnostics advance, the Global Multimodal Imaging Market is projected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Equipment
• Reagent
• Software

By Technology

• PET/CT Systems
• SPECT/CT Systems
• PET/MR Systems
• OCT/Fundus Imaging Systems
• Other Multimodal Imaging Systems

By Application

• Oncology
• Ophthalmology
• Cardiology
• Brain & Neurology
• Other Applications

By End User

• Hospitals
• Diagnostic Imaging Centres
• Other

COMPANIES PROFILED

• GE Healthcare, Siemens Healthcare GmbH, Toshiba medical Systems Corporation, Hitachi Medical Systems, Samsung Medison CoLtd, Koninklijke Philips NV, Shimadzu Corporation, Carestream Health, Fujifilm Holdings, Esaote
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MULTIMODAL IMAGING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MULTIMODAL IMAGING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. PET/CT Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. SPECT/CT Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. PET/MR Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. OCT/Fundus Imaging Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Multimodal Imaging Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MULTIMODAL IMAGING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Brain & Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MULTIMODAL IMAGING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Imaging Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MULTIMODAL IMAGING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MULTIMODAL IMAGING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 GE Healthcare
  • 10.2.2 Siemens Healthcare GmbH
  • 10.2.3 Toshiba Medical Systems Corporation
  • 10.2.4 Hitachi Medical Systems
  • 10.2.5 Samsung Medison Co.Ltd
  • 10.2.6 Koninklijke Philips N.V
  • 10.2.7 Shimadzu Corporation
  • 10.2.8 Carestream Health
  • 10.2.9 Fujifilm Holdings
  • 10.2.10 Esaote